Literature DB >> 10839351

Autoimmunity to gephyrin in Stiff-Man syndrome.

M H Butler1, A Hayashi, N Ohkoshi, C Villmann, C M Becker, G Feng, P De Camilli, M Solimena.   

Abstract

Stiff-Man syndrome (SMS) is a rare disease of the central nervous system (CNS) characterized by chronic rigidity, spasms, and autoimmunity directed against synaptic antigens, most often the GABA-synthesizing enzyme glutamic acid decarboxylase (GAD). In a subset of cases, SMS has an autoimmune paraneoplastic origin. We report here the identification of high-titer autoantibodies directed against gephyrin in a patient with clinical features of SMS and mediastinal cancer. Gephyrin is a cytosolic protein selectively concentrated at the postsynaptic membrane of inhibitory synapses, where it is associated with GABA(A) and glycine receptors. Our findings provide new evidence for a close link between autoimmunity directed against components of inhibitory synapses and neurological conditions characterized by chronic rigidity and spasms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10839351     DOI: 10.1016/s0896-6273(00)81165-4

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  41 in total

Review 1.  Immune mediated diseases and immune modulation in the neurocritical care unit.

Authors:  Gloria von Geldern; Thomas McPharlin; Kyra Becker
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

Review 2.  Autoimmune stiff person syndrome and related myelopathies: understanding of electrophysiological and immunological processes.

Authors:  Goran Rakocevic; Mary Kay Floeter
Journal:  Muscle Nerve       Date:  2012-05       Impact factor: 3.217

Review 3.  Losing your nerves? Maybe it's the antibodies.

Authors:  Betty Diamond; Patricio T Huerta; Paola Mina-Osorio; Czeslawa Kowal; Bruce T Volpe
Journal:  Nat Rev Immunol       Date:  2009-06       Impact factor: 53.106

4.  Paraneoplastic neurological syndromes: general treatment overview.

Authors:  Aurélien Viaccoz; Jérôme Honnorat
Journal:  Curr Treat Options Neurol       Date:  2013-04       Impact factor: 3.598

5.  Anti-GAD antibody positive stiff-limb syndrome in multiple myeloma.

Authors:  David Schiff; Josep Dalmau; Delynne J Myers
Journal:  J Neurooncol       Date:  2003-11       Impact factor: 4.130

Review 6.  Gephyrin: a master regulator of neuronal function?

Authors:  Shiva K Tyagarajan; Jean-Marc Fritschy
Journal:  Nat Rev Neurosci       Date:  2014-03       Impact factor: 34.870

Review 7.  Paraneoplastic movement disorders.

Authors:  Shyamal H Mehta; John C Morgan; Kapil D Sethi
Journal:  Curr Neurol Neurosci Rep       Date:  2009-07       Impact factor: 5.081

8.  Stiff person syndrome: advances in pathogenesis and therapeutic interventions.

Authors:  Marinos C Dalakas
Journal:  Curr Treat Options Neurol       Date:  2009-03       Impact factor: 3.598

9.  The glycinergic system in human startle disease: a genetic screening approach.

Authors:  Jeff S Davies; Seo-Kyung Chung; Rhys H Thomas; Angela Robinson; Carrie L Hammond; Jonathan G L Mullins; Eloisa Carta; Brian R Pearce; Kirsten Harvey; Robert J Harvey; Mark I Rees
Journal:  Front Mol Neurosci       Date:  2010-03-23       Impact factor: 5.639

10.  Stiff person-syndrome IgG affects presynaptic GABAergic release mechanisms.

Authors:  Christian Werner; Holger Haselmann; Andreas Weishaupt; Klaus V Toyka; Claudia Sommer; Christian Geis
Journal:  J Neural Transm (Vienna)       Date:  2014-07-03       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.